ArticleProceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine2026
Structural validation of novel bileaflet mechanical heart valve hinge mechanism.
Article in Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The structural performance of hinges in mechanical heart valves (MHVs) is essential for durability and reliability. This study evaluates the iValve, a novel bileaflet MHV, using advanced finite element method (FEM) simulations to assess its hinge design under physiological and supra-physiological conditions. The hinge design aims to minimize stress concentrations, reduce wear, and enhance durability compared to conventional valves. A detailed 3D FEM model, incorporating precise hinge geometry, was developed to analyze stress distribution, deformation, and potential failure zones. While our study uses a quasi-static finite element approach, and thus does not capture full dynamic or fluid-structure interactions, it evaluates peak physiological loading conditions representative of the cardiac cycle. The results show a lower and more uniform stress distribution in the iValve compared to conventional bileaflet MHVs, suggesting reduced stress concentrations and potentially improved fatigue life. The model was validated against experimental data from in vitro flow simulators, ensuring accurate representation of the hemodynamic forces during the cardiac cycle. Results show that the iValve's hinge design achieves superior stress distribution with significantly lower peak von Mises stresses than traditional designs. Optimized materials and geometric features reduce the risk of fatigue and wear, while high-cycle fatigue simulations confirmed minimal deformation, demonstrating suitability for extended use. This study highlights the role of FEM in advancing MHV design by balancing mechanical performance with physiological compatibility. The iValve addresses hinge failure and thrombus risks, offering a durable, anticoagulation-free solution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.